» Articles » PMID: 26388206

Development of a Diagnostic Test Based on Multiple Continuous Biomarkers with an Imperfect Reference Test

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2015 Sep 22
PMID 26388206
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Ignoring the fact that the reference test used to establish the discriminative properties of a combination of diagnostic biomarkers is imperfect can lead to a biased estimate of the diagnostic accuracy of the combination. In this paper, we propose a Bayesian latent-class mixture model to select a combination of biomarkers that maximizes the area under the ROC curve (AUC), while taking into account the imperfect nature of the reference test. In particular, a method for specification of the prior for the mixture component parameters is developed that allows controlling the amount of prior information provided for the AUC. The properties of the model are evaluated by using a simulation study and an application to real data from Alzheimer's disease research. In the simulation study, 100 data sets are simulated for sample sizes ranging from 100 to 600 observations, with a varying correlation between biomarkers. The inclusion of an informative as well as a flat prior for the diagnostic accuracy of the reference test is investigated. In the real-data application, the proposed model was compared with the generally used logistic-regression model that ignores the imperfectness of the reference test. Conditional on the selected sample size and prior distributions, the simulation study results indicate satisfactory performance of the model-based estimates. In particular, the obtained average estimates for all parameters are close to the true values. For the real-data application, AUC estimates for the proposed model are substantially higher than those from the 'traditional' logistic-regression model.

Citing Articles

Can T1-Weighted Magnetic Resonance Imaging Significantly Improve Mini-Mental State Examination-Based Distinguishing Between Mild Cognitive Impairment and Early-Stage Alzheimer's Disease?.

Marcisz A, Polanska J J Alzheimers Dis. 2023; 92(3):941-957.

PMID: 36806505 PMC: 10116132. DOI: 10.3233/JAD-220806.


Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard - An update.

Umemneku Chikere C, Wilson K, Graziadio S, Vale L, Allen A PLoS One. 2019; 14(10):e0223832.

PMID: 31603953 PMC: 6788703. DOI: 10.1371/journal.pone.0223832.


Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Weiner M, Veitch D, Aisen P, Beckett L, Cairns N, Green R Alzheimers Dement. 2017; 13(4):e1-e85.

PMID: 28342697 PMC: 6818723. DOI: 10.1016/j.jalz.2016.11.007.

References
1.
Garrett E, Zeger S . Latent class model diagnosis. Biometrics. 2000; 56(4):1055-67. DOI: 10.1111/j.0006-341x.2000.01055.x. View

2.
. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

3.
OMalley A, Zou K, Fielding J, Tempany C . Bayesian regression methodology for estimating a receiver operating characteristic curve with two radiologic applications: prostate biopsy and spiral CT of ureteral stones. Acad Radiol. 2001; 8(8):713-25. DOI: 10.1016/s1076-6332(03)80578-0. View

4.
Schisterman E, Faraggi D, Reiser B . Adjusting the generalized ROC curve for covariates. Stat Med. 2004; 23(21):3319-31. DOI: 10.1002/sim.1908. View

5.
Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B . Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2004; 51(2):336-45. DOI: 10.1373/clinchem.2004.039347. View